Table 1. HIV-1 drug-resistance mutation lists.
ANRS | IAS | REGA | STAN | SDRM | ||
---|---|---|---|---|---|---|
Nucleoside reverse-transcriptase inhibitors mutations* | ||||||
M41 | L | L | L | L | L | |
E44 | D | – | A/D | – | – | |
A62 | – | V | – | – | – | |
K65 | R | R | N/R | N/R | R | |
D67 | N | N | G/N/del | N | E/N/G | |
T69 | D/N/S/i | i | A/N/D/G/i | i | D/i | |
K70 | R | E/R | E/G/R | E/G/R | E/R | |
L74 | I/V | V | I/V | I/V | I/V | |
V75 | A/M/S/T | I | A/I/M/S/T | I/M/T | A/M/S/T | |
F77 | – | L | L | L | L | |
Y115 | F | F | F | F | F | |
F116 | – | Y | Y | Y | Y | |
V118 | – | – | I | – | – | |
Q151 | M | M | M | M | M | |
M184 | I/V | I/V | I/V | I/V | I/V | |
L210 | W | W | W | W | W | |
T215 | Mul‡ | F/Y | Mul‡ | F/Y | C/D/E/F/I/S/V/Y | |
K219 | E/Q | E/Q | E/H/N/R/Q | E/Q | E/N/R/Q | |
Non-nucleoside reverse-transcriptase inhibitors mutations* | ||||||
V90 | I | I | I | – | – | |
A98 | G/S§ | G | G | G | – | |
L100 | I | I | I | I | I | |
K101 | E/P | E/H/P | E/H/N/P/Q | E/P | E/P | |
K103 | H/N/S/T | N | H/N/R/S/T | N/S | N/S | |
V106 | A/I/M | A/I/M | A/I/M | A/M | A/M | |
V108 | – | I | I | I | – | |
E138 | – | A | K/Q | – | – | |
V179 | D/F | D/F/T | D/E | D/E/F | F | |
Y181 | C/I/V | C/I/V | C/I/V | C/I/V | C/I/V | |
Y188 | C/L/H | C/L/H | C/L/H | C/L/H | C/L/H | |
G190 | Mul¶ | A/S | Mul¶ | A/E/S | A/E/S | |
H221 | – | – | Y | – | – | |
P225 | H | H | H | H | H | |
F227 | – | – | C/L | C/L | – | |
M230 | L | L | I/L | L | L | |
P236 | – | – | L | L | – | |
K238 | – | – | N/T | T | – | |
Y318 | – | – | F | – | – | |
Protease inhibitors mutations* | ||||||
L10 | F/I/M/R/V | C/F/I/R/V | I/F/V/Y | – | – | |
V11 | I | I | I/L | – | – | |
I13 | – | V | – | – | – | |
I15 | A/V | – | – | – | – | |
G16 | E | E | – | – | – | |
K20 | I/M/R/T | I/M/R/T/V | I/M/R/T/V | – | – | |
L23 | – | – | I | I | I | |
L24 | I | I | F/I | I | I | |
D30 | N | N | N | N | N | |
V32 | I | I | I/L | I | I | |
L33 | F/I/V | F/I/V | F/I/M/V | F | – | |
E34 | – | Q | V | – | – | |
E35 | – | G | G/N | – | – | |
M36 | I/L/V | I/L/V | – | – | – | |
L38 | – | – | W | – | – | |
R41 | – | – | I/T | – | – | |
K43 | – | T | R/T | – | – | |
K45 | – | – | I | – | – | |
M46 | I/L | I/L | I/L | I/L | I/L | |
I47 | A/V | A/V | A/V | A/V | A/V | |
G48 | V | V | A/M/V | M/V | M/V | |
I50 | L/V | L/V | L/V | L/V | L/V | |
F53 | L/W/Y | L/Y | L | L | L/Y | |
I54 | A/L/M/S/T/V | A/L/M/S/T/V | A/C/L/M/S/T/V | A/L/M/T/V | A/L/M/S/T/V | |
Q58 | E | E | E | - | – | |
D60 | E | E | – | – | – | |
I62 | V | V | V | – | – | |
L63 | P | P | – | – | – | |
I64 | – | L/M/V | M/V | – | – | |
I66 | – | – | F | – | – | |
H69 | I/K/N/Q/R/Y | K | – | – | – | |
K70 | – | – | E | – | – | |
A71 | I/L/T/V | I/L/T/V | I/L/T/V | – | – | |
G73 | A/S/T | A/C/S/T | A/C/F/S/T/V | S/T | A/C/S/T | |
T74 | P | P | A/E/S/P | – | – | |
L76 | V | V | V | V | V | |
V77 | I | I | A/T/V | – | – | |
V82 | A/C/G/F/M/S/T | A/F/L/I/S/T | A/F/L/M/S/T | A/F/L/S/T | A/C/F/L/M/S/T | |
N83 | – | D | D | – | D | |
I84 | A/V | V | A/C/V | A/C/V | A/C/V | |
I85 | V | V | V | – | V | |
N88 | D/S | D/S | D/S | D/S | D/S | |
L89 | I/M/R/T/V | V | I/T/V | – | – | |
L90 | M | M | M | M | M | |
I93 | – | L/M | M | – | – | |
C95 | – | – | F | - | - |
Positions in bold have mutations that appear in all five lists.
Wild-type amino acid (for consensus subtype B sequence) and reverse transcriptase or protease position.
ANRS: T215A/C/D/E/F/G/H/I/L/N/S/V/Y.
For subtype C only.
ANRS: G190A/C/E/Q/S/T/V.
–: Mutation not on list; A: Alanine; ANRS: The French National Agency for AIDS Research, v17 [302]; C: Cysteine; D: Aspartic acid; del: Deletion; E: Glutamic acid; F: Phenylalanine; G: Glycine; H: Histidine; i: Insertion; I: Isoleucine; IAS: International AIDS Society–USA; K: Lysine; L: Leucine; M: Methionine; Mul: Multiple mutations; N: Asparagine; P: Proline; Q: Glutamine; R: Arginine; REGA: Rega Institute mutation list [304]; S: Serine; SDRM: Surveillance drug-resistance mutation list; STAN: Stanford University HIV Drug Resistance Database [303]; T: Threonine; V: Valine; W: Tryptophan; Y: Tyrosine.